GUGGENHEIM CAPITAL LLC - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 43 filers reported holding CLEVELAND BIOLABS INC in Q2 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q2 2014$11,000
-38.9%
23,549
-9.1%
0.00%
Q1 2014$18,000
-21.7%
25,903
+29.4%
0.00%
Q4 2013$23,000
-20.7%
20,020
+6.3%
0.00%
Q3 2013$29,000
-3.3%
18,8360.0%0.00%
Q2 2013$30,00018,8360.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q2 2013
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 697,300$1,102,0000.26%
GOODNOW INVESTMENT GROUP, LLC 601,889$951,0000.17%
MACROVIEW INVESTMENT MANAGEMENT LLC 38,000$60,0000.06%
BHR Capital LLC 300,000$474,0000.05%
LADENBURG THALMANN FINANCIAL SERVICES INC. 746,200$1,172,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 67,200$106,0000.02%
Van Cleef Asset Management,Inc 20,000$32,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 69,981$111,0000.01%
KINGS POINT CAPITAL MANAGEMENT 10,000$16,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$24,0000.01%
View complete list of CLEVELAND BIOLABS INC shareholders